Verekitug

CAT: 0931-T9901A-507-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0931-T9901A-507-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
2768386-15-6
Target
Immunology/Inflammation related|||Interleukin
Related Pathways
Immunology/Inflammation
Purity
0.989
Bioactivity
Verekitug is a novel, recombinant, fully human monoclonal antibody developed to selectively target thymic stromal lymphopoietin receptor (TSLPR) with high potency. Verekitug is currently being investigated as a potential therapeutic candidate for severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP), where overactivation of TSLPR contributes to disease pathology. Verekitug offers a promising approach to immune modulation in respiratory and inflammatory disease research.
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName

Alternative Products

CatalogName
HY-P990774-01Verekitug
HP521016-01Research Grade Verekitug
E55B1102Verekitug (Reference antibody)
ICH5975-5mgVerekitug Biosimilar - Research Grade
A138613Verekitug Biosimilar (Monoclonal, IgG1)
12-90367-100Anti-CRLF2 (verekitug biosimilar) mAb
RA0149-01Verekitug (Biosimilar Reference Antibody) (CRLF2)
CSB-RA005983MA1HU-01CRLF2 (Verekitug) Recombinant Monoclonal Antibody
A137035Verekitug Biosimilar (Monoclonal, IgG1-kappa)
MBS1881865-01Biotinylated Anti-CRLF2 (verekitug biosimilar) mAb

Popular Products